References
- Meyskens F L, Fuller B B. Characterization of the effects of different retinoids on the growth and differentiation of a human melanoma cell line and selected subclones. Cancer Res 1980; 40: 2194–2196
- Kameyama K, Tanaka S, Ishida Y, et al. Interferons modulate the expression of hormone receptors on the surface of murine melanoma cells. J Clin Invest 1989; 83: 213–221
- Kirkwood J M, Ernstoff M S. Cutaneous melanoma. Biologic Therapy of Cancer, V T DeVita, S Hellman, S A Rosenberg. JB Lippincott, Philadelphia 1991; 311–333
- Smith M A, Parkinson D R, Cheson B D, et al. Retinoids in cancer therapy. J Clin Oncol 1992; 10: 839–864
- Meyskens F, Gilmartin E, Alberts D, et al. Activity of isoretinoin against squamous cell cancers and preneoplastic lesions. Cancer Treat Rep 1982; 66: 1315–1319
- Goodman G. Phase II trial of retinol in patients with advanced cancer. Cancer Treat Rep 1986; 70: 1023–1024
- Levine N, Meyskens F. Topical vitamin A acid therapy for cutaneous metastatic melanoma. Lancet 1980; 2: 224–226
- Modiano M, Dalton W, Lippman S, et al. Phase II study of fenretinide (n-[4-hydroxyphenyl]retinide) in advanced breast cancer and melanoma. Invest New Drugs 1990; 8: 317–319
- Meyskens F, Kopecky K, Costanzi J, et al. A randomized phase II trial of high dose vitamin A versus placebo for stage I malignant melanoma. Proc Am Soc Clin Oncol 1988; 7: 247
- Hemmi H, Breitman T R. Combinations of recombinant human interferon and retinoic acid synergistically induced differentiation of the human promyelocytic leukemia cell line HL-60. Blood 1987; 69: 501–507
- Frey J R, Peck R, Bollag W. Antiproliferative activity of retinoids, interferon-α and their combination in five human transformed cell lines. Cancer Lett 1991; 57: 223–227
- Lippman S M, Parkinson D R, Itri L M, et al. 13-cis retinoic acid and interferon α-2a: Effective combination therapy for advanced squamous cell carcinoma of the skin. J Natl Cancer Inst 1992; 84: 235–241
- Lippman S M, Kavanagh J J, Paredes-Espinoza M, et al. 13-cis retinoic acid plus interferon α-2a: Highly active systemic therapy for squamous cell carcinoma of the cervix. J Natl Cancer Inst 1992; 84: 241–245
- Triozzi P L, Eicher D M, Smoot J, et al. Modulation of leukemic cell sensitivity to lymphokine activated killer cytolysis: Role of intercellular adhesion molecule-1. Exp Hematol 1992; 20: 1072–1076
- Triozzi P L, Sedwick W D, Hand H, et al. The induction of 2′-5′ oligoadenylate synthetase activity in peripheral blood mononuclear cells by gamma interferon. J Biol Resp Mod 1986; 5: 562–570